Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

The Professor of Genetics sat down with Fifteen Minutes to discuss anti-aging research, the wellness industry, and his ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

Ramona, a Durham provider of advanced imaging technology for life sciences, has launched a live-cell imaging system that ...

With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

North Texas took center stage as a global hub for innovation during Advanced Therapies Week (ATW) 2025. This signature event showcased the intersection of cutting-edge science, transformative ...

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...